311 related articles for article (PubMed ID: 22331072)
1. [Neuro-urological dysfunction of the lower urinary tract in CNS diseases: pathophysiology, epidemiology, and treatment options].
Mehnert U; Nehiba M
Urologe A; 2012 Feb; 51(2):189-97. PubMed ID: 22331072
[TBL] [Abstract][Full Text] [Related]
2. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders.
Sakakibara R; Panicker J; Finazzi-Agro E; Iacovelli V; Bruschini H;
Neurourol Urodyn; 2016 Jun; 35(5):551-63. PubMed ID: 25810035
[TBL] [Abstract][Full Text] [Related]
3. Management of neurogenic bladder in patients with multiple sclerosis.
Phé V; Chartier-Kastler E; Panicker JN
Nat Rev Urol; 2016 May; 13(5):275-88. PubMed ID: 27030526
[TBL] [Abstract][Full Text] [Related]
4. Brain activation patterns of female multiple sclerosis patients with voiding dysfunction.
Khavari R; Chen J; Boone T; Karmonik C
Neurourol Urodyn; 2020 Mar; 39(3):969-977. PubMed ID: 32032447
[TBL] [Abstract][Full Text] [Related]
5. Integrated control of lower urinary tract--clinical perspective.
Fowler CJ
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S14-24. PubMed ID: 16465178
[TBL] [Abstract][Full Text] [Related]
6. Effective management of lower urinary tract dysfunction in idiopathic Parkinson's disease.
Kapoor S; Bourdoumis A; Mambu L; Barua J
Int J Urol; 2013 Jan; 20(1):79-84. PubMed ID: 23281786
[TBL] [Abstract][Full Text] [Related]
7. What is the utility of urodynamics, including ambulatory, and 24 h monitoring, in predicting upper urinary tract damage in neuro-urological patients and other lower urinary tract dysfunction? ICI-RS 2017.
Rantell A; Lu Y; Averbeck MA; Badawi JK; Rademakers K; Tarcan T; Cardozo L; Djurhuus JC; Castro-Diaz D
Neurourol Urodyn; 2018 Jun; 37(S4):S25-S31. PubMed ID: 30024052
[TBL] [Abstract][Full Text] [Related]
8. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series.
Engeler DS; Meyer D; Abt D; Müller S; Schmid HP
BMC Urol; 2015 Oct; 15():105. PubMed ID: 26498275
[TBL] [Abstract][Full Text] [Related]
9. The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
Tornic J; Panicker JN
Curr Neurol Neurosci Rep; 2018 Jun; 18(8):54. PubMed ID: 29956001
[TBL] [Abstract][Full Text] [Related]
10. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis).
Fowler CJ; van Kerrebroeck PE; Nordenbo A; Van Poppel H
J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):986-9. PubMed ID: 1469417
[TBL] [Abstract][Full Text] [Related]
11. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.
Sakakibara R
Clin Auton Res; 2019 Jun; 29(3):313-320. PubMed ID: 30076494
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of the neuro-urological patient: a systematic review.
Averbeck MA; Madersbacher H
BJU Int; 2015 Apr; 115 Suppl 6():39-46. PubMed ID: 25891319
[TBL] [Abstract][Full Text] [Related]
13. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
Chen G; Liao L; Wang Y; Ying X
Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
[TBL] [Abstract][Full Text] [Related]
14. Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Scheepe JR; Wong YY; van Pelt ED; Ketelslegers IA; Catsman-Berrevoets CE; van den Hoek J; Hintzen RQ; Neuteboom RF
Mult Scler; 2016 Oct; 22(11):1490-1494. PubMed ID: 26589894
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings.
Schöps TF; Schneider MP; Steffen F; Ineichen BV; Mehnert U; Kessler TM
BJU Int; 2015 Apr; 115 Suppl 6():33-8. PubMed ID: 25891318
[TBL] [Abstract][Full Text] [Related]
16. Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction.
Barboglio Romo PG; Gupta P
Urol Clin North Am; 2017 Aug; 44(3):453-461. PubMed ID: 28716325
[TBL] [Abstract][Full Text] [Related]
17. [Sacral neuromodulation for neurogenic bladder dysfunction].
Kessler TM; Wöllner J; Kozomara M; Mordasini L; Mehnert U
Urologe A; 2012 Feb; 51(2):179-83. PubMed ID: 22269992
[TBL] [Abstract][Full Text] [Related]
18. Functional Magnetic Resonance Imaging with Concurrent Urodynamic Testing Identifies Brain Structures Involved in Micturition Cycle in Patients with Multiple Sclerosis.
Khavari R; Karmonik C; Shy M; Fletcher S; Boone T
J Urol; 2017 Feb; 197(2):438-444. PubMed ID: 27664581
[TBL] [Abstract][Full Text] [Related]
19. Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis.
Medina-Polo J; Adot JM; Allué M; Arlandis S; Blasco P; Casanova B; Matías-Guiu J; Madurga B; Meza-Murillo ER; Müller-Arteaga C; Rodríguez-Acevedo B; Vara J; Zubiaur MC; López-Fando L
Neurourol Urodyn; 2020 Feb; 39(2):762-770. PubMed ID: 31943361
[TBL] [Abstract][Full Text] [Related]
20. Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury.
Redshaw JD; Lenherr SM; Elliott SP; Stoffel JT; Rosenbluth JP; Presson AP; Myers JB;
BMC Urol; 2018 Aug; 18(1):72. PubMed ID: 30157824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
